期刊文献+

健择联合顺铂治疗晚期非小细胞肺癌50例临床观察

原文传递
导出
摘要 我国肺癌的发病率呈逐年上升趋势,其病死率在恶性肿瘤的死因构成中占第3位,部分城市已跃居第1位[1],严重地威胁着人们的健康和生命。非小细胞肺癌(Nonsmall cell lung cancer,NSCLC),占所有肺癌的75%-80%,因缺乏特异性临床表现,约30%-40%的NSCLC确诊时已为Ⅲ-Ⅳ期,化疗成为重要的治疗手段。
出处 《福州总医院学报》 2010年第4期244-244,243,共2页 Journal of Fuzhou General Hospital
  • 相关文献

参考文献7

  • 1孔令文,吴庆琛.FHIT基因、吸烟与肺癌[J].第三军医大学学报,2004,26(10):930-931. 被引量:4
  • 2Sp ira A, Ettinger DS. Multidiscip linary management of lung cancer. N Engl J Med, 2004, 350 (4) : 379.
  • 3陈克能,张力建.化疗在进展期非小细胞肺癌治疗中的地位及其进展[J].国外医学(呼吸系统分册),2000,20(1):48-51. 被引量:42
  • 4Robert F , Spencer S A , Childa H A 3rd , et al. Concurrent chemoradiation therapy with cisplatin and paclitaxel for locally ad- vanced non- small cell lung cancer: long - term follow - up of a phase I trial. LungCancer , 2002 , 37 (2) : 189 - 199.
  • 5James LA, Kalf G, Earle A, et all A phase I clinical , plasma and cellular pharmacology study of gemcitabine 1 J Clin Oncol , 1991, 9 (3) : 491 -498.
  • 6管忠震,陈茹琴,徐光川,李宇红,许立功,李龙云,刘叙仪,廖美琳,李金瀚.Gemcitabine治疗晚期非小细胞肺癌的临床研究[J].癌症,1999,18(3):241-245. 被引量:177
  • 7Hansen HH, Sorensen JB. Efficacy of single - agent gemcitabine in advanced non - small cell lung cancer: a review. Semin Oncol , 1997 24 (2 Supp 17) : S7.

二级参考文献20

  • 1Stein C K, Glover T W, Palmer J L, et al. Direct correlation between FRA3B expression and cigarette smoking[J]. Genes Chromosomes Cancer, 2002, 34(3): 333-340.
  • 2Askari M D, Miller G H, Vo-Dinh T. Simultaneous detection of the tumor suppressor FHIT gene and protein using the multi-functional biochip[J]. Cancer Detect Prev, 2002, 26(5): 331-342.
  • 3Geradts J, Fong K M, Zimmerman P V, et al. Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features[J]. Br J Cancer, 2000, 82(6): 1191-1197.
  • 4Fong L Y, Fidanza V, Zanesi N, et al. Muir-Torre-like syndrome in Fhit-deficient mice[J]. Proc Natl Acad Sci USA, 2000, 97(9): 4742-4747.
  • 5Dumon K R, Ishii H, Fong L Y, et al. FHIT gene therapy prevents tumor development in Fhit-deficient mice[J]. Proc Natl Acad Sci USA, 2001, 98(6): 3346-3351.
  • 6Parkin D M, Bray F I, Devesa S S. Cancer burden in the year 2000. The global picture[J]. Eur J Cancer, 2001, 37(Suppl 8): S4-66.
  • 7Tyczynski J E, Bray F, Parkin D M. Lung cancer in Europe in 2000: epidemiology, prevention, and early detection[J]. Lancet Oncol, 2003, 4(1): 45-55.
  • 8Fong K M, Sekido Y, Gazdar A F, et al. Molecular biology of lung cancer: clinical implications[J]. Thorax, 2003, 58(10): 892-900.
  • 9Pylkkanen L, Wolff H, Stjernvall T, et al. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients[J]. Int J Oncol, 2002, 20(2): 285-290.
  • 10Pekarsky Y, Zanesi N, Palamarchuk A, et al. FHIT: from gene discovery to cancer treatment and prevention[J]. Lancet Oncol, 2002, 3(12): 748-754.

共引文献219

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部